Ronald P. DeMatteo
Ronald P. DeMatteo publishes mostly in Surgery, Oncology and Hepatology, on topics such as Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies and Gastrointestinal Tumor Research and Treatment.
- World rank
- #6,927 of 7,710,434 ranked researchers
- Rank in United States
- #2,376 of 1,627,098
- Works
- 923
- Citations
- 78k
- Citations per work
- 84.4
What does Ronald P. DeMatteo research?
Ronald P. DeMatteo's work is mostly in Medicine (71%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences65671.1%
- Medicine65671.1%
- Everything else19921.6%
- Life Sciences677.3%
- 1Surgery22% of their works
- 2Oncology16% of their works
- 3Hepatology13% of their works
- 4Pulmonary and Respiratory Medicine12% of their works
- 5Gastroenterology8% of their works
- 6Immunology7% of their works
Research topics
- Hepatocellular Carcinoma Treatment and Prognosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Gastrointestinal Tumor Research and Treatment
- Pancreatic and Hepatic Oncology Research
- Gallbladder and Bile Duct Disorders
- Colorectal Cancer Treatments and Studies
- Organ Transplantation Techniques and Outcomes
- Sarcoma Diagnosis and Treatment
Which keywords describe Ronald P. DeMatteo's research?
The keywords of their largest research topics: Prognostic Factors, Surgical Management, Clinical Practice Guidelines, Cholangiocarcinoma, Chemotherapy, Hepatocellular Carcinoma, Liver Cancer and Biliary Tract Cancer.
- Osteosarcoma
- Ischemia-Reperfusion Injury
- Cetuximab
- Cholecystitis
- Pancreatic Cancer
- Imatinib Mesylate
- Biliary Tract Cancer
- Hepatocellular Carcinoma
- Cholangiocarcinoma
- Surgical Management
- Prognostic Factors
- Clinical Practice Guidelines
- Chemotherapy
- Liver Cancer
- Intrahepatic Cholangiocarcinoma
- Sunitinib
- Surgical Complications
- ERCP
- KRAS Mutations
- Liver Transplantation
- Soft Tissue Sarcoma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Prognostic Factors3873 topics
- Surgical Management3322 topics
- Clinical Practice Guidelines2962 topics
- Cholangiocarcinoma2632 topics
- Chemotherapy2573 topics
- Hepatocellular Carcinoma2411 topic
- Liver Cancer2411 topic
- Biliary Tract Cancer1811 topic
- Intrahepatic Cholangiocarcinoma1811 topic
- Imatinib Mesylate1511 topic
- Sunitinib1511 topic
- Pancreatic Cancer1421 topic
- Surgical Complications1421 topic
- Cholecystitis821 topic
- ERCP821 topic
- Cetuximab601 topic
- KRAS Mutations601 topic
- Ischemia-Reperfusion Injury571 topic
- Liver Transplantation571 topic
- Osteosarcoma551 topic
- Soft Tissue Sarcoma551 topic
Where does Ronald P. DeMatteo work?
Ronald P. DeMatteo's main affiliation in the publication record is Memorial Sloan Kettering Cancer Center, United States.
How many publications and citations does Ronald P. DeMatteo have?
OpenAlex counts 923 works and 77,863 citations for Ronald P. DeMatteo, an h-index of 141, ranking #6,927 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ronald P. DeMatteo. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.